Literature DB >> 21601635

N-hydroxyethyl-4-aza-didehydropodophyllotoxin derivatives as potential antitumor agents.

Ajay Kumar1, Vineet Kumar, Antonio E Alegria, Sanjay V Malhotra.   

Abstract

Three different series of N-hydroxyethyl aza-podophyllotoxin derivatives containing (i) a five-membered methylenedioxy ring (7a-f), (ii) a five-membered ring with no heteroatom (8a-f) or (iii) a six membered ethylenedioxy ring (9a-f) as ring A were synthesized using a convenient one-pot multi-component reaction. Further variation on ring E was done by decorating it with methoxy and hydroxy groups at different positions. Calculation of logP values of these compounds indicates them to be better soluble than corresponding non-hydroxy derivatives. These novel aza-podophyllotoxin derivatives were screened for their cytostatic and cytotoxic activities on National Cancer Institute's 60 human tumor cell lines to study the structure activity relationship. The overall anticancer activity of these compounds was in the order of 8a-f>9a-f>7a-f. Furthermore, the compounds having 3'-methoxy and 3',4',5'-trimethoxy substitution at ring E were the most active within the series. The cytotoxicity of all the active compounds was low, while their antiproliferative (or cytostatic) activity was high, providing a wide therapeutic window for their potential application as anticancer drugs.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601635      PMCID: PMC3278235          DOI: 10.1016/j.ejps.2011.04.013

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  24 in total

Review 1.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

2.  Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives.

Authors:  Zhiyan Xiao; Kenneth F Bastow; John R Vance; Robert S Sidwell; Hui-Kang Wang; Ming S Chen; Qian Shi; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

3.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

Review 4.  Antitumor properties of podophyllotoxin and related compounds.

Authors:  M Gordaliza; M A Castro; J M del Corral; A S Feliciano
Journal:  Curr Pharm Des       Date:  2000-12       Impact factor: 3.116

5.  Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.

Authors:  X K Zhu; J Guan; Y Tachibana; K F Bastow; S J Cho; H H Cheng; Y C Cheng; M Gurwith; K H Lee
Journal:  J Med Chem       Date:  1999-07-01       Impact factor: 7.446

6.  Nonenolizable podophyllotoxin derivatives.

Authors:  W J Gensler; C D Murthy; M H Trammell
Journal:  J Med Chem       Date:  1977-05       Impact factor: 7.446

Review 7.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

8.  4-Aza-2,3-dehydro-4-deoxypodophyllotoxins: simple aza-podophyllotoxin analogues possessing potent cytotoxicity.

Authors:  Y Hitotsuyanagi; M Fukuyo; K Tsuda; M Kobayashi; A Ozeki; H Itokawa; K Takeya
Journal:  Bioorg Med Chem Lett       Date:  2000-02-21       Impact factor: 2.823

9.  Antitumor agents. 144. New gamma-lactone ring-modified arylamino etoposide analogs as inhibitors of human DNA topoisomerase II.

Authors:  X M Zhou; K J Lee; J Cheng; S S Wu; H X Chen; X Guo; Y C Cheng; K H Lee
Journal:  J Med Chem       Date:  1994-01-21       Impact factor: 7.446

10.  Discovery and investigation of antiproliferative and apoptosis-inducing properties of new heterocyclic podophyllotoxin analogues accessible by a one-step multicomponent synthesis.

Authors:  Igor V Magedov; Madhuri Manpadi; Severine Van Slambrouck; Wim F A Steelant; Elena Rozhkova; Nikolai M Przheval'skii; Snezna Rogelj; Alexander Kornienko
Journal:  J Med Chem       Date:  2007-09-26       Impact factor: 7.446

View more
  4 in total

1.  Investigation on the Anticancer Activity of Symmetric and Unsymmetric Cyclic Sulfamides.

Authors:  Jaden Jungho Jun; Divya Duscharla; Ramesh Ummanni; Paul R Hanson; Sanjay V Malhotra
Journal:  ACS Med Chem Lett       Date:  2021-01-15       Impact factor: 4.345

2.  Biological Activity of N-Hydroxyethyl-4-aza-2,3-didehydropodophyllotoxin Derivatives upon Colorectal Adenocarcinoma Cells.

Authors:  Christian Vélez; Beatriz Zayas; Ajay Kumar
Journal:  Open J Med Chem       Date:  2014-03

3.  Synthesis and biological activity, and molecular modelling studies of potent cytotoxic podophyllotoxin-naphthoquinone compounds.

Authors:  Ha Thanh Nguyen; Quynh Giang Nguyen Thi; Thu Ha Nguyen Thi; Phuong Hoang Thi; Giang Le-Nhat-Thuy; Tuyet Anh Dang Thi; Bao Le-Quang; Hai Pham-The; Tuyen Van Nguyen
Journal:  RSC Adv       Date:  2022-08-09       Impact factor: 4.036

4.  Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells.

Authors:  Mirko Andreoli; Marco Persico; Ajay Kumar; Nausicaa Orteca; Vineet Kumar; Antonella Pepe; Sakkarapalayam Mahalingam; Antonio E Alegria; Lella Petrella; Laima Sevciunaite; Alessia Camperchioli; Marisa Mariani; Antonio Di Dato; Ettore Novellino; Giovanni Scambia; Sanjay V Malhotra; Cristiano Ferlini; Caterina Fattorusso
Journal:  J Med Chem       Date:  2014-09-26       Impact factor: 7.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.